✦ LIBER ✦

Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study

✍ Scribed by Michallet, M; Maloisel, F; Delain, M; Hellmann, A; Rosas, A; Silver, R T; Tendler, C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of recombinant interf

✍ Anger, B. ;Porzsolt, F. ;Leichtle, R. ;Heinze, B. ;Bartram, C. ;Heimpel, H. 📂 Article 📅 1989 🏛 Springer-Verlag ⚖ 337 KB

Recombinant alpha-2a interferon treatmen

✍ H. Ören; Ö. Düzovalı; G. Irken 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 175 KB

Recombinant alpha-2B interferon treatmen

✍ Stephen J. Lauer; Judith Ochs; Brad H. Pollock; George R. Buchanan 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Interferon alpha-2c therapy of patients

✍ J. Thaler; G. Gastl; T. Fluckinger; D. Niederwieser; H. Huber; H. Seewann; H. Si 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 228 KB

The safety of pegylated interferon alpha

✍ M. van Zonneveld; H. J. Flink; E. Verhey; H. Senturk; S. Zeuzem; U. S. Akarca; Y 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

A systematic review and economic evaluat

✍ A. Takeda; J. Jones; J. Shepherd; P. Davidson; A. Price 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB